Free Trial

Bellevue Healthcare (BBH) Competitors

Bellevue Healthcare logo
GBX 132 -3.80 (-2.80%)
(As of 11/15/2024 11:52 AM ET)

BBH vs. JGGI, BPT, RCP, HICL, MNKS, HGT, ABDN, PHLL, INPP, and SSON

Should you be buying Bellevue Healthcare stock or one of its competitors? The main competitors of Bellevue Healthcare include JPMorgan Global Growth & Income (JGGI), Bridgepoint Group (BPT), RIT Capital Partners (RCP), HICL Infrastructure (HICL), Monks (MNKS), HgCapital Trust (HGT), abrdn (ABDN), Petershill Partners (PHLL), International Public Partnerships (INPP), and Smithson Investment Trust (SSON). These companies are all part of the "asset management" industry.

Bellevue Healthcare vs.

JPMorgan Global Growth & Income (LON:JGGI) and Bellevue Healthcare (LON:BBH) are both financial services companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, community ranking, risk and analyst recommendations.

Bellevue Healthcare received 109 more outperform votes than JPMorgan Global Growth & Income when rated by MarketBeat users. Likewise, 68.52% of users gave Bellevue Healthcare an outperform vote while only 66.67% of users gave JPMorgan Global Growth & Income an outperform vote.

CompanyUnderperformOutperform
JPMorgan Global Growth & IncomeOutperform Votes
2
66.67%
Underperform Votes
1
33.33%
Bellevue HealthcareOutperform Votes
111
68.52%
Underperform Votes
51
31.48%

In the previous week, JPMorgan Global Growth & Income had 2 more articles in the media than Bellevue Healthcare. MarketBeat recorded 2 mentions for JPMorgan Global Growth & Income and 0 mentions for Bellevue Healthcare. JPMorgan Global Growth & Income's average media sentiment score of 1.18 beat Bellevue Healthcare's score of 0.00 indicating that JPMorgan Global Growth & Income is being referred to more favorably in the media.

Company Overall Sentiment
JPMorgan Global Growth & Income Positive
Bellevue Healthcare Neutral

14.9% of JPMorgan Global Growth & Income shares are owned by institutional investors. Comparatively, 40.6% of Bellevue Healthcare shares are owned by institutional investors. 7.9% of JPMorgan Global Growth & Income shares are owned by insiders. Comparatively, 0.1% of Bellevue Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

JPMorgan Global Growth & Income has a net margin of 93.49% compared to Bellevue Healthcare's net margin of 0.00%. JPMorgan Global Growth & Income's return on equity of 17.44% beat Bellevue Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
JPMorgan Global Growth & Income93.49% 17.44% 10.62%
Bellevue Healthcare N/A N/A N/A

JPMorgan Global Growth & Income pays an annual dividend of GBX 23 per share and has a dividend yield of 3.9%. Bellevue Healthcare pays an annual dividend of GBX 6 per share and has a dividend yield of 4.5%. JPMorgan Global Growth & Income pays out 2,643.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bellevue Healthcare pays out 3,750.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

JPMorgan Global Growth & Income has higher revenue and earnings than Bellevue Healthcare. JPMorgan Global Growth & Income is trading at a lower price-to-earnings ratio than Bellevue Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
JPMorgan Global Growth & Income£345.48M8.38£323M£0.87674.71
Bellevue HealthcareN/AN/AN/A£0.16825.00

Summary

JPMorgan Global Growth & Income beats Bellevue Healthcare on 9 of the 14 factors compared between the two stocks.

Get Bellevue Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BBH vs. The Competition

MetricBellevue HealthcareAsset Management IndustryFinancial SectorLON Exchange
Market Cap£721.58M£979.01M£3.28B£1.65B
Dividend Yield4.48%5.62%4.45%6.87%
P/E Ratio825.00782.97417.471,784.26
Price / SalesN/A3,233.333,471.57253,178.35
Price / CashN/A60.7751.0227.62
Price / BookN/A1.191.412.85
Net IncomeN/A£63.26M£381.16M£159.30M
7 Day Performance-6.25%-0.37%0.12%-0.63%
1 Month Performance-10.20%-0.81%0.23%3.41%
1 Year Performance3.13%11.45%16.18%126.74%

Bellevue Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BBH
Bellevue Healthcare
N/AGBX 132
-2.8%
N/A+3.0%£721.58MN/A825.00N/A
JGGI
JPMorgan Global Growth & Income
N/AGBX 589
+0.3%
N/A+20.8%£2.90B£345.48M677.01N/ADividend Announcement
Positive News
BPT
Bridgepoint Group
0.6774 of 5 stars
GBX 339.80
+2.5%
N/A+63.8%£2.80B£342.10M4,247.50391Gap Down
RCP
RIT Capital Partners
N/AGBX 1,892
+1.5%
N/A+9.8%£2.72B£314.90M1,167.9062News Coverage
HICL
HICL Infrastructure
N/AGBX 125.20
+1.3%
N/A-9.9%£2.53B£35.20M6,260.00N/ADividend Announcement
MNKS
Monks
N/AGBX 1,242
+0.8%
N/A+25.5%£2.51B£419.32M697.75N/A
HGT
HgCapital Trust
N/AGBX 541
+2.3%
N/A+37.6%£2.48B£255.96M1,082.00N/APositive News
ABDN
abrdn
0.9468 of 5 stars
GBX 138.85
+1.1%
N/A-18.0%£2.47B£1.41B816.764,719Positive News
PHLL
Petershill Partners
1.1856 of 5 stars
GBX 227
+0.4%
N/A+62.5%£2.45B£578.70M986.96N/ADividend Increase
News Coverage
INPP
International Public Partnerships
N/AGBX 129
+1.4%
N/A-6.6%£2.45B£66.07M12,900.00N/APositive News
SSON
Smithson Investment Trust
N/AGBX 1,468
+1.2%
N/A+15.3%£2.38BN/A646.70N/A

Related Companies and Tools


This page (LON:BBH) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners